Offering you a complete choice of products which include we-govy 0.25mg flextouch, we-govy 0.5mg flextouch, we-govy 1mg flextouch and moun-jaro 15mg injection.




₹ 6000 / PieceGet Latest Price
| Minimum Order Quantity | 10 Piece |
| Strength | 0.25 mg |
| Pack Type | Prefilled Pen |
| Volume | 1.5 ml |
| Brand | novo nordisk |
| Usage | Type 2 Diabetes |
| Storage Temp | 2–8°C |
| Injection Route | SC |
| Shelf Life | 24 months |
Product introduction
Wegovy 0.25mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 0.25mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 0.25mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.
Wegovy 0.25mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.
The most common side effects of Wegovy 0.25mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.
Before starting Wegovy 0.25mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).
Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 0.25mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.
Uses of Wegovy Injection
Management of Obesity
Risk Reduction of Heart disease
Common side effects of Wegovy
· Indigestion
· Dizziness
· Burping
· Hypoglycemia (low blood glucose level)
· Gastroenteritis
· Nasopharyngitis (inflammation of the throat and nasal passages)
· Constipation
· Nausea
· Vomiting
· Diarrhea



₹ 8200 / PieceGet Latest Price
| Minimum Order Quantity | 100 Piece |
| Strength | 0.5 mg |
| Pack Type | Prefilled Pen |
| Volume | 1.5 ml |
| Brand | novo nordisk |
| Usage | Weight Loss, Type 2 Diabetes |
| Storage Temp | 2–8°C |
| Injection Route | SC |
| Shelf Life | 24 months |
Product introduction
Wegovy 0.5mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 0.5mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 0.5mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.
Wegovy 0.5mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.
The most common side effects of Wegovy 0.5mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.
Uses of Wegovy Injection
Management of Obesity
Risk Reduction of Heart disease
Side effects of Wegovy Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Wegovy
· Indigestion
· Dizziness
· Burping
· Hypoglycemia (low blood glucose level)
· Gastroenteritis
· Nasopharyngitis (inflammation of the throat and nasal passages)
· Constipation
· Nausea
· Vomiting
· Diarrhea
· Stomach pain



₹ 9200 / PieceGet Latest Price
| Minimum Order Quantity | 100 Piece |
| Strength | 1 mg |
| Pack Type | Prefilled Pen |
| Volume | 3 ml |
| Brand | novo nordisk |
| Usage | Type 2 Diabetes |
| Storage Temp | 2–8°C |
| Injection Route | SC |
| Shelf Life | 24 months |
Product introduction
Wegovy 1mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 1mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 1mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.
Wegovy 1mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits
The most common side effects of Wegovy 1mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.
Uses of Wegovy Injection
· Management of Obesity
· Risk Reduction of Heart disease
Side effects of Wegovy Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Wegovy
· Indigestion
· Dizziness
· Burping
· Hypoglycemia (low blood glucose level)
· Gastroenteritis
· Nasopharyngitis (inflammation of the throat and nasal passages)
· Constipation
· Nausea
· Vomiting
· Diarrhea
· Stomach pain


₹ 25000 / VialGet Latest Price
| Minimum Order Quantity | 10 Vial |
| Brand | Tirzepatide |
| Strength | 15 mg/0.5 ml |
| Pack Size | 1 prefilled pen |
| Delivery Form | Prefilled Pen |
| Application | Weight Management, Type 2 Diabetes |
| Prescription Type | Rx Only |
| Storage Temperature | 2–8°C |
| Shelf Life | 24 months |
| Usage | Human Use |
| Country Of Origin | USA |
Mounjaro 15mg KwikPen
Product introduction
Mounjaro 15mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 15mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 15mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Uses of Mounjaro Solution for Injection
· To improve glycemic control in adults with Type 2 diabetes mellitus
· Management of Obesity
Benefits of Mounjaro Solution for Injection
In To improve glycemic control in adults with Type 2 diabetes mellitus
Mounjaro 15mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.
In Management of Obesity
Mounjaro 15mg KwikPen supports weight loss in individuals with obesity when used in conjunction with a healthy diet and regular exercise. It helps reduce appetite and calorie intake, making it easier to eat healthy and maintain a healthier lifestyle. In obese individuals, weight reduction decreases the risk of obesity-related conditions like heart disease, high blood pressure, and type 2 diabetes.
Side effects of Mounjaro Solution for Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mounjaro
· Nausea
· Vomiting
· Diarrhea
· Abdominal pain
· Indigestion
· Constipation
Dipesh Kakadiya (Owner)
Corsantrum Technology
1st Floor, Office No. 114, Katargam, Mahek Icon, Surat - 395008, Gujarat, India


